The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical useof the medicinal product (registration certificate LSR-005900/08 dated 23.07.2008 issued by GlaxoSmithKline Trading, Russia):
Avandamet
(trade name of the medicinal product)
Metformin +Rosiglitazone
(international non-proprietary or chemical name of the medicinal product)
Tablets, film-coated, 2 mg + 1000 mg, 4 mg + 1000 mg
(dosage form, dosage)
Glaxo Wellcome SA, Spain
Avda de Extremadura 3, 09400 Aranda de Duero, Burgos, Spain
(name and address of the location of the manufacturer of the medicinal product)
on the basis of filing an application by an authorized legal entity of ZAO GlaxoSmithKline Trading to cancel the state registration of the medicinal product.